Advertisement

Journal of Public Health Policy

, Volume 31, Issue 4, pp 478–493 | Cite as

Hepatitis B vaccination of adolescents: A report on the national program in Iran

  • Seyed Moayed Alavian
  • Nima Zamiri
  • Mohammad Mehdi Gooya
  • Alireza Tehrani
  • Seyyed Taghi Heydari
  • Kamran B Lankarani
Original Article

Abstract

Since 2007, Iran's Ministry of Health carried out a nationwide hepatitis-B vaccination campaign for 17-year-old adolescents in four stages. We report the outcomes of the second and third stages targeting adolescents born during 1990 and 1991. The National Committee for Hepatitis selected a passive approach – media education – for mass vaccination. (A community mobilization strategy, for example, would be termed active.) The target populations in 2008 and 2009 included 1 709 337 and 1 673 571 adolescents. In each year, Iran organized three rounds of vaccination throughout the country. At the end of each round, data were collected and sent to Ministry of Health for analysis. The overall coverage rate was 74.9 per cent for one dose of vaccination, and 62.76 per cent for all three doses in 2008; 75.7 per cent and 55.6 per cent, respectively in 2009. Coverage rates in rural areas were significantly higher (P<0.001). The media education approach achieved acceptable outcomes in current campaign. Constant performance monitoring, and perhaps a new catch-up vaccination campaign are warranted to expand coverage.

Keywords

hepatitis B vaccination national campaign coverage rate adolescents 

References

  1. World Health Organization (WHO). (2008) Hepatitis B Fact Sheet. Num.204, http://www.who.int/mediacentre/factsheets/fs204/en/index.html, updated August 2008.
  2. Alavian, S., Hajarizadeh, B., Ahmadzad-Asl, M., Kabir, A. and Lankarani, K.B. (2008) Hepatitis B virus infection in Iran: A systematic review. Journal of Hepatitis Monthly 8 (4): 281–294.Google Scholar
  3. Alavian, S.M., Fallahian, F. and Lankarani, K.B. (2007) The changing epidemiology of viral hepatitis B in Iran. Journal of Gastrointestinal and Liver Disease 16 (4): 403–406.Google Scholar
  4. Lavanchy, D. (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. Journal of Viral Hepatitis 11 (2): 97–107.CrossRefGoogle Scholar
  5. Mast, E.E. et al (2005) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices part 1: Immunization of infants, children, and adolescents. MMWR Recommendations and Reports 54 (RR-16): 1–31.Google Scholar
  6. Daniels, D., Grytdal, S. and Wasley, A. (2009) Surveillance for acute viral hepatitis – United States, 2007. MMWR Surveillance Summaries 58 (3): 1–27.Google Scholar
  7. Mast, E.E. et al (2006) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices Part II: Immunization of adults. MMWR Recommendations and Reports 55 (RR-16): 1–33, ; quiz CE1-4.Google Scholar
  8. Alavian, S. (2007) Ministry of health in Iran is serious about controlling hepatitis B. Journal of Hepatitis Monthly 7 (1): 3–5.Google Scholar
  9. Alavian, S.M. et al (2009) Mass vaccination campaign against hepatitis B in adolescents in Iran: Estimating coverage using administrative data. Journal of Hepatitis Monthly 9 (3): 189–195.Google Scholar
  10. Joulaei, H., Honarvar, B., Zamiri, N., Moghadami, M. and Lankarani, K.B. (2010) Introduction of a pyramidal model based on primary health care: A paradigm for management of 2009 H1N1 flu pandemic. Iranian Red Crescent Medical Journal 12 (3): 224–230.Google Scholar
  11. Statistical Center of Iran. (2008) The results of National Population and Housing Census in Oct 2006. (cited 28 April 2008), http://www.sci.org.ir/portal/faces/public/census85/census85.natayej.Google Scholar
  12. Euler, G.L. (2001) The epidemiology of hepatitis B vaccination catch-up among AAPI children in the United States. Asian American and Pacific Islander Journal of Health 9 (2): 154–161.Google Scholar
  13. Liu, H., Hynes, K., Lim, J.M. and Chung, H.I. (2001) Hepatitis B catch-up project: Analysis of 1999 data from the Chicago public schools. Asian American and Pacific Islander Journal of Health 9 (2): 205–210.Google Scholar
  14. McPhee, S.J. et al (2003) Successful promotion of hepatitis B vaccinations among Vietnamese-American children ages 3 to 18: Results of a controlled trial. Pediatrics 111 (6.1): 1278–1288.CrossRefGoogle Scholar
  15. Deuson, R.R., Brodovicz, K.G., Barker, L., Zhou, F. and Euler, G.L. (2001) Economic analysis of a child vaccination project among Asian Americans in Philadelphia. Pa Arch Pediatr Adolesc Med 155 (8): 909–914.CrossRefGoogle Scholar
  16. Zhou, F. et al (2003) Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas. Pediatrics 111 (6): 1289–1296.CrossRefGoogle Scholar
  17. Krahn, M., Guasparini, R., Sherman, M. and Detsky, A.S. (1998) Costs and cost-effectiveness of a universal, school-based hepatitis B vaccination program. American Journal of Public Health 88 (11): 1638–1644.CrossRefGoogle Scholar
  18. Van Damme, P., Meheus, A. and Kane, M. (1998) Control of hepatitis B in Europe: Where are we in 1997? Concluding remarks. Vaccine 16 (Suppl.): 109–110.CrossRefGoogle Scholar
  19. Dilraj, A., Strait-Jones, J., Nagao, M., Cui, K., Terrell-Perica, S. and Effler, P.V. (2003) A statewide hepatitis B vaccination program for school children in Hawaii: Vaccination series completion and participation rates over consecutive school years. Public Health Reports 118 (2): 127–133.CrossRefGoogle Scholar
  20. Koff, R.S. (2000) Hepatitis B school-based vaccination programmes in the USA: A model for hepatitis A and B. Vaccine 18 (1): S77–9.CrossRefGoogle Scholar
  21. Deuson, R.R. et al (1999) The Denver school-based adolescent hepatitis B vaccination program: A cost analysis with risk simulation. American Journal of Public Health 89 (11): 1722–1727.CrossRefGoogle Scholar
  22. Zali, M.R., Mohammad, K., Noorbala, A.A., Noorimayer, B. and Shahraz, S. (2005) Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. Eastern Mediterranean Health Journal 11 (1–2): 62–67.Google Scholar
  23. Asadi-Lari, M., Sayyari, A.A., Akbari, M.E. and Gray, D. (2004) Public health improvement in Iran-lessons from the last 20 years. Public Health 118 (6): 395–402.CrossRefGoogle Scholar
  24. Aghajanian, A., Mehryar, A.H., Ahmadnia, S. and Kazemipour, S. (2007) Impact of rural health development programme in the Islamic Republic of Iran on rural-urban disparities in health indicators. Eastern Mediterranean Health Journal 13 (6): 1466–1475.Google Scholar
  25. Van Damme, P. (2001) Hepatitis B: Vaccination programmes in Europe – An update. Vaccine 19 (17–19): 2375–2379.CrossRefGoogle Scholar
  26. Alavian, S., Fallahian, F. and Lankarani, K.B. (2007) Comparison of seroepidemiology and transmission modes of viral Hepatitis B in Iran and Pakistan. Journal of Hepatitis Monthly 7 (4): 6.Google Scholar
  27. Cassidy, W. (1998) School-based adolescent hepatitis B immunization programs in the United States: Strategies and successes. The Pediatric Infectious Disease Journal 17 (7): S43–S46.CrossRefGoogle Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2010

Authors and Affiliations

  • Seyed Moayed Alavian
    • 1
  • Nima Zamiri
    • 2
  • Mohammad Mehdi Gooya
    • 3
  • Alireza Tehrani
    • 1
  • Seyyed Taghi Heydari
    • 2
  • Kamran B Lankarani
    • 2
  1. 1.Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical SciencesTehranIran
  2. 2.Health Policy Research Center, Shiraz University of Medical SciencesShirazIran
  3. 3.Center for Disease Control, Ministry of Health and Medical Education of I.R. IranTehranIran

Personalised recommendations